Tse-I Lin
12Patents
4h-index
31Co-inventors
56Inventor score
Filing activity: Oct 25, 2003 → Jan 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8022077B2 | Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof | Human Necessities | 29 | Expired |
| US8030318B2 | Fused bicyclic inhibitors of HCV | Human Necessities | 28 | Expired |
| US7977342B2 | HCV inhibiting bi-cyclic pyrimidines | Emerging Cross-Sectional Technologies | 8 | Active |
| US7960387B2 | 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses | Human Necessities | 4 | Expired |
| US7709491B2 | Substituted quinazolines as antiviral agents, especially against cytomegaloviruses | Human Necessities | 3 | Active |
| US8921355B2 | Macrocyclic indole derivatives useful as hepatitis C virus inhibitors | Chemistry; Metallurgy | 3 | Active |
| US9290502B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US9427440B2 | Macrocyclic indole derivatives useful as hepatitis C virus inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9987277B2 | Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C | Human Necessities | 0 | Active |
| US9708328B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11891601B2 | Method to enhance the transcription regulation of SUPT4H on genes containing repetitive nucleotide sequences | Chemistry; Metallurgy | 0 | Active |
| US9951075B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.